ALLMedicine™ Schnitzler Syndrome Center
Research & Reviews 109 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677784
Arthritis Research & Therapy; Darrieutort-Laffite C, Ansquer C et. al.
Nov 19th, 2020 - To report on the characteristics and long-term course of rheumatic manifestations in Schnitzler syndrome (SchS). A retrospective cohort study of patients with SchS followed between 2000 and 2020. Inclusion criteria included a diagnosis of SchS (St...
https://doi.org/10.1007/s10067-020-05204-2
Clinical Rheumatology; Yan R, Cao W et. al.
Jun 8th, 2020 - Schnitzler syndrome (SchS) is a rare acquired systemic autoinflammatory disease. The major clinical features of SchS are urticarial rash and monoclonal gammopathy, accompanied by fever, joint pain, and lymphadenopathy. There were few reports about...
https://doi.org/10.1016/j.semarthrit.2020.05.002
Seminars in Arthritis and Rheumatism; Betrains A, Staels F et. al.
Jun 5th, 2020 - Schnitzler syndrome is a rare autoinflammatory disorder characterized by chronic urticarial rash and a monoclonal gammopathy, accompanied by intermittent fever, bone pain, and arthralgia or arthritis. Canakinumab is a fully human monoclonal anti-i...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081793
Clinical Medicine (London, England); Zampeli E, Marinos L et. al.
Mar 19th, 2020 - Images of the month 1: Schnitzler syndrome: an acquired autoinflammatory syndrome.|2020|Zampeli E,Marinos L,Karakatsanis SJ,|
https://doi.org/10.1016/j.jaci.2019.12.909
The Journal of Allergy and Clinical Immunology; Krause K, Bonnekoh H et. al.
Jan 15th, 2020 - Long-term efficacy of canakinumab in the treatment of Schnitzler syndrome.|2020|Krause K,Bonnekoh H,Ellrich A,Tsianakas A,Wagner N,|
Clinicaltrials.gov 109 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677784
Arthritis Research & Therapy; Darrieutort-Laffite C, Ansquer C et. al.
Nov 19th, 2020 - To report on the characteristics and long-term course of rheumatic manifestations in Schnitzler syndrome (SchS). A retrospective cohort study of patients with SchS followed between 2000 and 2020. Inclusion criteria included a diagnosis of SchS (St...
https://doi.org/10.1007/s10067-020-05204-2
Clinical Rheumatology; Yan R, Cao W et. al.
Jun 8th, 2020 - Schnitzler syndrome (SchS) is a rare acquired systemic autoinflammatory disease. The major clinical features of SchS are urticarial rash and monoclonal gammopathy, accompanied by fever, joint pain, and lymphadenopathy. There were few reports about...
https://doi.org/10.1016/j.semarthrit.2020.05.002
Seminars in Arthritis and Rheumatism; Betrains A, Staels F et. al.
Jun 5th, 2020 - Schnitzler syndrome is a rare autoinflammatory disorder characterized by chronic urticarial rash and a monoclonal gammopathy, accompanied by intermittent fever, bone pain, and arthralgia or arthritis. Canakinumab is a fully human monoclonal anti-i...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081793
Clinical Medicine (London, England); Zampeli E, Marinos L et. al.
Mar 19th, 2020 - Images of the month 1: Schnitzler syndrome: an acquired autoinflammatory syndrome.|2020|Zampeli E,Marinos L,Karakatsanis SJ,|
https://doi.org/10.1016/j.jaci.2019.12.909
The Journal of Allergy and Clinical Immunology; Krause K, Bonnekoh H et. al.
Jan 15th, 2020 - Long-term efficacy of canakinumab in the treatment of Schnitzler syndrome.|2020|Krause K,Bonnekoh H,Ellrich A,Tsianakas A,Wagner N,|
News 1 results
https://www.mdedge.com/dermatology/article/86939/urticaria/successful-treatment-schnitzler-syndrome-canakinumab
Robbie Pesek, MD, Roger Fox, MD
Sep 3rd, 2014 - To the Editor: Schnitzler syndrome occurs with a triad of chronic urticaria, recurring fevers, and monoclonal gammopathy. It was recognized as a clinical entity in 1972; now nearly 200 patients are reported in the medical literature.
